-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
DiaMedica Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2017 to 2023.
- DiaMedica Therapeutics Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$6.88M, a 33.5% decline year-over-year.
- DiaMedica Therapeutics Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$24.1M, a 24.3% decline year-over-year.
- DiaMedica Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$21.3M, a 51.9% decline from 2022.
- DiaMedica Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$14M, a 2.6% decline from 2021.
- DiaMedica Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$13.6M, a 7.46% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)